scholarly journals Calcium Phosphate Barrier for Augmentation of Bone in noncontained Periodontal Osseous Defects: A Novel Approach

2014 ◽  
Vol 15 (6) ◽  
pp. 779-783 ◽  
Author(s):  
Aditi Chopra ◽  
Karthik Sivaraman ◽  
Tarun K Awataramaney

ABSTRACT Aim The aim of this technique is to augment bone in noncontained osseous deformities using a unique self-sustaining calcium phosphate barrier. Introduction Bone has the inherent ability to regenerate completely if it is provided with a fracture space or an undisturbed enclosed scaffold. A secluded environment is essential as it provides a secured, sterile and stable wound system that regenerates lost bone by a process of osteopromotion. Reconstructive techniques using bone grafts and barrier membranes utilize this principle for augmentation of deficient bony sites by providing a closed environment that promotes clot stability, graft retention, and facilitates correct cell repopulation. However, in noncontained bone defects like one walled infrabony periodontal defect or sites with horizontal bone loss, regeneration of bone still remains an unrealistic situation since osseous topography at such sites does not favor membrane stability or bone grafts retention. This case report presents a promising technique to augment bone in areas with horizontal loss. Technique Augmentation of bone in the interdental area with horizontal bone loss was accomplished by building a contained defect using a unique self sustaining calcium phosphate cement formulation. The calcium phosphate barrier stimulates the lost cortical plates and promotes graft retention and clot stability. At 6 months, there was a significant bone fill and trabecular formation in the interdental area and reduction in tooth mobility. Conclusion This promising technique could prove to be a good alternative to the conventional approaches for treating osseous deformities. Clinical significance Calcium phosphate is a promising barrier graft for repair of noncontained periodontal osseous defect. This technique cues both the clinicians and manufacturers to develop moldable tissue engineered constructs for osseous repair. How to cite this article Chopra A, Sivaraman K, Awataramaney TK. Calcium Phosphate Barrier for Augmentation of Bone in noncontained Periodontal Osseous Defects: A Novel Approach. J Contemp Dent Pract 2014;15(6):779-783.

Injury ◽  
2017 ◽  
Vol 48 (12) ◽  
pp. 2807-2813 ◽  
Author(s):  
Alexander Hanke ◽  
Martin Bäumlein ◽  
Siegmund Lang ◽  
Boyko Gueorguiev ◽  
Michael Nerlich ◽  
...  

2006 ◽  
Vol 7 (3) ◽  
pp. 22-29
Author(s):  
Farah Masood ◽  
Christos Angelopoulos ◽  
Alan Glaros

Abstract Aim The purpose of this study was to compare two types of conventional radiographic film: Ekta-speed plus and Insight (Eastman Kodak Co, Rochester NY, USA) for accuracy of measurements of approximal bone loss. Methods and Materials Four dried human mandibles with complete dentition were selected. Radiographic images were made with a standardized technique. Mesial and distal bone levels on the mandibular premolar and molar teeth were measured on the two types of radiographs (Ekta-speed plus and Insight) by nine observers. The data obtained by the observers were compared with the primary investigators’ corresponding measurements, which served as “the ground truth” for this study. Results The results of the analysis of variance (ANOVA) demonstrated a significant difference for the Ektaspeed plus film (p = .001), but the difference was not clinically significant. The level of intra-rater reliability was high for the observers (0.969 to 0.990). Conclusion Performance of Ekta-speed plus and Insight films was found to be similar. Citation Masood F, Angelopoulos C, Glaros A. A Comparison Between Two Types of Radiographic Film for Accuracy of Measurements of Approximal Osseous Defects. J Contemp Dent Pract 2006 July;(7)3:022-029.


2018 ◽  
Vol 28 (1) ◽  
pp. 17-21 ◽  
Author(s):  
Waseem Ahmed ◽  
Muhammad Adil Asim ◽  
Afeefa Ehsan ◽  
Qalab Abbas

2018 ◽  
Vol 2018 ◽  
pp. 1-7 ◽  
Author(s):  
Vadims Klimecs ◽  
Alexanders Grishulonoks ◽  
Ilze Salma ◽  
Laura Neimane ◽  
Janis Locs ◽  
...  

Biphasic calcium phosphate ceramic granules (0.5–1.0 mm) with a hydroxyapatite and β-tricalcium phosphate ratio of 90/10 were used. Biphasic calcium phosphate ceramic granules produced in the Riga Technical University, Riga Rudolph Cimdins Biomaterials Innovation and Development Centre, were used for filling the bone loss on 18 patients with peri-implantitis. After 5 years at the minimum, clinical and 3D cone-beam computed tomography control was done. Clinical situation confirmed good stability of implants without any signs of inflammation around. Radiodensity of the previous gap and alveolar bone horizontally from middle point of dental implants showed similar radiodensity as in normal alveolar bone. This trial is registered with ISRCTN13514478.


2012 ◽  
Vol 24 (2) ◽  
pp. 417-436 ◽  
Author(s):  
Mareike Lalk ◽  
Janin Reifenrath ◽  
Nina Angrisani ◽  
Alexandr Bondarenko ◽  
Jan-Marten Seitz ◽  
...  

Blood ◽  
2012 ◽  
Vol 119 (2) ◽  
pp. 540-550 ◽  
Author(s):  
Benjamin J. Frisch ◽  
John M. Ashton ◽  
Lianping Xing ◽  
Michael W. Becker ◽  
Craig T. Jordan ◽  
...  

Pancytopenia is a major cause of morbidity in acute myeloid leukemia (AML), yet its cause is unclear. Normal osteoblastic cells have been shown to support hematopoiesis. To define the effects of leukemia on osteoblastic cells, we used an immunocompetent murine model of AML. Leukemic mice had inhibition of osteoblastic cells, with decreased serum levels of the bone formation marker osteocalcin. Osteoprogenitor cells and endosteal-lining osteopontin+ cells were reduced, and osteocalcin mRNA in CD45− marrow cells was diminished. This resulted in severe loss of mineralized bone. Osteoclasts were only transiently increased without significant increases in bone resorption, and their inhibition only partially rescued leukemia-induced bone loss. In vitro data suggested that a leukemia-derived secreted factor inhibited osteoblastic cells. Because the chemokine CCL-3 was recently reported to inhibit osteoblastic function in myeloma, we tested its expression in our model and in AML patients. Consistent with its potential novel role in leukemic-dependent bone loss, CCL-3 mRNA was significantly increased in malignant marrow cells from leukemic mice and from samples from AML patients. Based on these results, we propose that therapeutic mitigation of leukemia-induced uncoupling of osteoblastic and osteoclastic cells may represent a novel approach to promote normal hematopoiesis in patients with myeloid neoplasms.


Sign in / Sign up

Export Citation Format

Share Document